Azacitidine Patent Expiration
Azacitidine is Used for continued treatment of adults with acute myeloid leukemia who achieved first complete remission following intensive chemotherapy. It was first introduced by Bristol-Myers Squibb Co
Azacitidine Patents
Given below is the list of patents protecting Azacitidine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Onureg | US11571436 | Oral formulations of cytidine analogs and methods of use thereof | May 14, 2029 | Bristol |
| Onureg | US8846628 | Oral formulations of cytidine analogs and methods of use thereof | Jun 03, 2030 | Bristol |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Azacitidine Generics
Several generic applications have been filed for Azacitidine. The first generic version for Azacitidine was by Dr Reddys Laboratories Ltd and was approved on Sep 16, 2013. And the latest generic version is by Msn Laboratories Private Ltd and was approved on May 16, 2024.
Given below is the list of companies who have filed for Azacitidine generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Jul 2, 2018 |
2. CIPLA
Cipla Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | May 4, 2018 |
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Sep 16, 2013 |
4. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Feb 3, 2022 |
5. MSN LABS PVT LTD
Msn Laboratories Private Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Msn Labs Pvt Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | May 16, 2024 |
6. LUPIN LTD
Lupin Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Discontinued | INTRAVENOUS, SUBCUTANEOUS | N/A | Feb 27, 2019 |
7. MYLAN INSTITUTIONAL
Mylan Institutional Llc has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Mylan Institutional.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Discontinued | INTRAVENOUS, SUBCUTANEOUS | N/A | Apr 28, 2016 |
8. SHILPA MEDICARE
Shilpa Medicare Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Shilpa Medicare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Sep 29, 2016 |
9. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Nov 2, 2020 |
10. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Dec 30, 2022 |
11. EUROHLTH INTL SARL
Eurohealth International Sarl has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Eurohlth Intl Sarl.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Jun 8, 2020 |
12. NATCO PHARMA LTD
Natco Pharma Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Natco Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Jun 23, 2017 |
13. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 1 generic for Azacitidine. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | powder | Prescription | INTRAVENOUS, SUBCUTANEOUS | AP | Jun 28, 2023 |